Onconetix (ONCO) Assets (2021 - 2026)
Onconetix (ONCO) posted quarterly Assets of $14.8 million for Q1 2026, down 21.0% year-over-year from $18.8 million in Q1 2025, and down 40.5% quarter-over-quarter from $24.9 million in Q4 2025.
Onconetix (ONCO) Assets (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Assets for 6 consecutive years, with $14.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 21.0% year-over-year to $14.8 million; the TTM figure through Mar 2026 stood at $14.8 million (down 21.0% YoY), while the FY2025 annual figure was $24.9 million, down 11.55% from the prior year.
- Assets retreated to $14.8 million in Q1 2026 per ONCO's latest filing, from $24.9 million in the prior quarter.
- Across five years, Assets topped out at $87.5 million in Q4 2023 and bottomed at $860204.0 in Q3 2022.
- Historically, Assets has averaged $23.3 million across 5 years, with a median of $19.3 million in 2022.
- Annual changes were most pronounced in 2023 — Assets soared 10074.1% — and 2024, when it tumbled 76.47%.
- Onconetix's Assets stood at $860204.0 in 2022, then jumped by 10074.1% to $87.5 million in 2023, then slumped by 67.8% to $28.2 million in 2024, then retreated by 11.55% to $24.9 million in 2025, then sank by 40.5% to $14.8 million in 2026.
- Business Quant data shows ONCO's Assets at $14.8 million in Q1 2026, $24.9 million in Q4 2025, and $19.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 16.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.43 Mn |
| Mar 31, 2026 | 14.83 Mn |
| Dec 31, 2025 | 24.93 Mn |
| Sep 30, 2025 | 19.68 Mn |
| Jun 30, 2025 | 19.12 Mn |
| Mar 31, 2025 | 18.78 Mn |
| Dec 31, 2024 | 28.18 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 75.03 Mn |
| Dec 31, 2023 | 87.52 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 29.75 Mn |
| Mar 31, 2023 | 22.50 Mn |
| Dec 31, 2022 | 860,204.00 |
| Sep 30, 2022 | 860,204.00 |
| Jun 30, 2022 | 23.63 Mn |
| Mar 31, 2022 | 19.34 Mn |
| Dec 31, 2021 | 3.08 Mn |